US Stock MarketDetailed Quotes
ALNY Alnylam Pharmaceuticals
- 240.550
- +4.600+1.95%
Close Jan 8 16:00 ET
- 241.080
- +0.530+0.22%
Pre 05:31 ET
31.03BMarket Cap-91.81P/E (TTM)
240.650High234.106Low653.99KVolume236.340Open235.950Pre Close156.43MTurnover0.51%Turnover RatioLossP/E (Static)128.98MShares304.39052wk High958.37P/B30.89BFloat Cap141.97552wk Low--Dividend TTM128.43MShs Float304.390Historical High--Div YieldTTM2.77%Amplitude3.650Historical Low239.193Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Alnylam Pharmaceuticals Stock Forum
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet